Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection
Author:
- 16 January 2009
- journal article
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 44 (S19) , 82-88
Abstract
In addition to the link with development of hepatocellular carcinoma (HCC), hepatitis C virus (HCV) infection is associated with several hepatic and extrahepatic manifestations. A role of hepatic steatosis in the pathogenesis of chronic hepatitis C has been shown, implying hepatitis C as a metabolic disease. Furthermore, recent epidemiological studies have suggested a linkage between insulin resistance and chronic HCV infection. In addition to the data indicating the presence of lipid metabolism disturbance and insulin resistance in the cohort of chronic hepatitis C patients, we found evidence showing the association between these two conditions and HCV infection using mice transgenic for the HCV core gene. These mice develop HCC late in life after the phase of hepatic steatosis and insulin resistance. The nonappearance of both steatosis and HCC in HCV core gene transgenic mice that are null for the proteasome activator 28γ implies a close relationship between lipid metabolism disturbance and hepatocarcinogenesis. Also, the core protein is shown to bind with retinoid X receptor (RXR)-α, resulting in the upregulation of some lipid metabolism enzymes, including cellular retinol binding protein II and acyl-CoA oxidase. In addition, the persistent activation of peroxisome proliferator activated receptor (PPAR)-α has recently been found in the liver of HCV core gene transgenic mice, yielding dramatic changes in lipid metabolism and hepatocyte proliferation, including HCC development. These results would provide a clue for further understanding of the role of lipid metabolism in pathogenesis of HCV infection, including liver injury and hepatocarcinogenesis.Keywords
This publication has 35 references indexed in Scilit:
- PPARα activation is essential for HCV core protein–induced hepatic steatosis and hepatocellular carcinoma in miceJournal of Clinical Investigation, 2008
- Hepatitis C as a systemic disease: virus and host immunologic responses underlie hepatic and extrahepatic manifestationsJournal of Gastroenterology, 2007
- Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator‐activated receptor α in transgenic mice: Implications for HCV‐associated hepatocarcinogenesisInternational Journal of Cancer, 2007
- Involvement of the PA28γ-Dependent Pathway in Insulin Resistance Induced by Hepatitis C Virus Core ProteinJournal of Virology, 2007
- Critical role of PA28γ in hepatitis C virus-associated steatogenesis and hepatocarcinogenesisProceedings of the National Academy of Sciences, 2007
- Insulin resistance and HCV: Will new knowledge modify clinical management?Journal of Hepatology, 2006
- Hepatitis C Virus Triggers Mitochondrial Permeability Transition with Production of Reactive Oxygen Species, Leading to DNA Damage and STAT3 ActivationJournal of Virology, 2006
- Steatosis: Co-factor in Other Liver Diseases *Hepatology, 2005
- Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic miceHepatology, 2003
- Hepatitis C Virus Core Protein Activates Erk and P38 Mapk in Cooperation With Ethanol in Transgenic MiceHepatology, 2003